Halaven 0.5mg Injection

About Halaven 0.5mg Injection

Halaven 0.5mg Injection contains Eribulin, an anticancer medication that belongs to the class of antineoplastic agents. It is primarily used to treat advanced or metastatic breast cancer and liposarcoma, a rare type of cancer that develops in fat tissue, particularly when previous treatment options have not been effective. Eribulin works by interfering with cancer cell growth and division, helping to slow the progression and spread of the disease. Halaven 0.5mg Injection is administered under the supervision of a healthcare professional and is intended for adult patients. This medication should not be used by individuals who are allergic to Eribulin or any of its ingredients, and its safety and effectiveness have not been established in children and adolescents under 18 years of age. Before starting treatment, patients should inform their doctor about any history of fever, ongoing infections, liver disease, heart conditions, or other significant medical problems. It is also important to provide a complete list of prescription medicines, over-the-counter drugs, and supplements being taken to help prevent potential interactions and ensure safe treatment. Regular monitoring during therapy may be recommended to manage side effects and optimize treatment outcomes.